44 results on '"Van de Velde, C."'
Search Results
2. 138MO Prognostic performance of Breast Cancer Index (BCI) in postmenopausal women with early-stage HR+ breast cancer in the TEAM trial
3. Should rectal cancer located 10–15 cm from the anal verge be defined as colon cancer
4. 9P Long term recurrence risk predictions by CanAssist breast in a sub-cohort of TEAM trial
5. Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)—first results from PathIES†
6. Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009
7. Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial
8. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy
9. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial†
10. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008
11. P-131 An international patient-centered outcome measurement set for colorectal cancer
12. Quality assurance in the treatment of colorectal cancer: the EURECCA initiative
13. Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)
14. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype
15. O-4 Average cumulative relative dose of adjuvant chemotherapy is more important than average relative dose intensity for colorectal cancer survival, with implications for treating obese patients: The OCTOPUS consortium
16. 7P An optimized Breast Cancer Index node-positive (BCIN+) prognostic model for late distant recurrence in patients with hormone receptor-positive (HR+) node-positive breast cancer
17. Quantitative assessment of lymph vascular space invasion (LVSI) provides important prognostic information in node-negative breast cancer
18. Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis
19. Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer†
20. The prognostic role of TGF-β signaling pathway in breast cancer patients
21. Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patients
22. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
23. Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers
24. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010
25. Maintenance of physical activity and body weight in relation to subsequent quality of life in postmenopausal breast cancer patients
26. Management of isolated nonresectable liver metastases in colorectal cancer patients: a case–control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy
27. Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases
28. Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial
29. Current role of surgery and multimodal treatment in localized gastric cancer
30. The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007
31. Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients
32. The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006
33. The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005
34. Surgical aspects of colorectal cancer
35. Gastric cancer: epidemiology, pathology and treatment
36. Sentinel lymph node biopsy in breast cancer
37. Gastric cancer: staging and surgery
38. Adjuvant chemotherapy in node negative breast cancer: Patterns of use and oncologists' preferences
39. Validating the CTS5 algorithm with the IDEAL study cohort
40. 92O - Validating the CTS5 algorithm with the IDEAL study cohort
41. Clinical and Morphological Characteristics of P53-Positive Breast Cancer Stage I in Russian and Dutch Populations
42. Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous Carcinoma
43. 290P - Clinical and Morphological Characteristics of P53-Positive Breast Cancer Stage I in Russian and Dutch Populations
44. O-0015 - Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.